España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Chimerix
CMRX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.940000
0.04
4.46%
Pre-Market: Jul 19, 9:27 AM EDT
15 minutes delayed
Get Report
Comment
Chimerix (CMRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Chimerix (NASDAQ:CMRX) Stock
Chimerix Stock (NASDAQ: CMRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 01, 2024
Chimerix Expects Dordaviprone Interim Overall...
Benzinga Newsdesk
Chimerix Q1 2024 GAAP EPS $(0.25) Misses $(0....
Benzinga Newsdesk
Thursday, April 11, 2024
WHO's Tedros Adhanom Ghebreyesus Posts On X "...
Benzinga Newsdesk
Friday, March 01, 2024
HC Wainwright & Co. Reiterates Buy on Chimeri...
Benzinga Newsdesk
Thursday, February 29, 2024
Chimerix Q4 Cash and Equivalents $204M
Benzinga Newsdesk
Chimerix Q4 EPS $(0.20) Beats $(0.24) Estimat...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Preview: Chimerix's Earnings
Benzinga Insights
Friday, December 08, 2023
Reported Earlier, "WHO 'Very Worried' About S...
Benzinga Newsdesk
Monday, December 04, 2023
Chimerix Announced The Promotion Of Michelle ...
Benzinga Newsdesk
Friday, November 17, 2023
COO and CCO at Chimerix Acquires Company Stock Options Worth 800,000 Shares
Benzinga Insights
Thursday, November 02, 2023
Chimerix Expects To End 2023 With Over $200M ...
Benzinga Newsdesk
Chimerix Q3 EPS $(0.27) Misses $(0.23) Estima...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Wednesday, November 01, 2023
Earnings Outlook For Chimerix
Benzinga Insights
Wednesday, September 27, 2023
NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying
Lisa Levin
Monday, September 18, 2023
Overview Of Value Stocks In The Healthcare Sector
Benzinga Insights
Friday, August 18, 2023
'CHP Investigates Two Confirmed Mpox Cases' -...
Benzinga Newsdesk
Thursday, August 17, 2023
4 Analysts Have This to Say About Chimerix
Benzinga Insights
Wedbush Reiterates Outperform on Chimerix, Ma...
Benzinga Newsdesk
Wednesday, August 16, 2023
HC Wainwright & Co. Reiterates Buy on Chimeri...
Benzinga Newsdesk
Chimerix Announces Data Highlighting Clinical Efficacy And Molecular Mechanisms Of Response To ONC201 Treatment Of H3 K27M-Mutant Diffuse Midline Gliomas Published In "Cancer Discovery"
Happy Mohamed
Friday, August 11, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, August 09, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, August 07, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 04, 2023
HC Wainwright & Co. Reiterates Buy on Chimeri...
Benzinga Newsdesk
Thursday, August 03, 2023
CORRECTION: Chimerix Q2 EPS $(0.21) Beats $(0...
Benzinga Newsdesk
Chimerix Q2 EPS $(0.21) Beats $(0.24) Estimat...
Benzinga Newsdesk
Earnings Scheduled For August 3, 2023
Benzinga Insights
Friday, July 28, 2023
'27 Confirmed Monkeypox Cases Reported In India: Government To Lok Sabha' - The Economic Times
Happy Mohamed
Friday, July 07, 2023
Global Times Tweets "Three cases of monkeypox were discovered on July 5 in Changsha, Central China's Hunan. Local health authorities have initiated an epidemiological investigation, and the cases involve three males aged 24, 28, and 38, respectively..."
Happy Mohamed
Tuesday, June 27, 2023
Chimerix Announces Promotion Of Michael T. An...
Benzinga Newsdesk
Chimerix Promotes Michael T. Andriole To Pres...
Benzinga Newsdesk
Tuesday, June 06, 2023
2 Cases Of Mpox Detected In Beijing
Benzinga Newsdesk
Tuesday, May 23, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
Benzinga Insights
Baird Initiates Coverage On Chimerix with Out...
Benzinga Newsdesk
Monday, May 22, 2023
A Look Into Healthcare Sector Value Stocks
Benzinga Insights
Friday, May 12, 2023
Report of Mpox Cases Rising in Vaccinated People In Chicago, France
Charles Gross
Thursday, May 11, 2023
World Health Organization Says Mpox Is No Longer A Global Health Emergency
Happy Mohamed
Wednesday, May 10, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, May 09, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, May 05, 2023
HC Wainwright & Co. Reiterates Buy on Chimeri...
Benzinga Newsdesk
Thursday, May 04, 2023
Chimerix: Q1 Earnings Insights
Benzinga Insights
Chimerix Q1 EPS $(0.24) Beats $(0.25) Estimat...
Benzinga Newsdesk
Earnings Scheduled For May 4, 2023
Benzinga Insights
Wednesday, May 03, 2023
Chimerix Earnings Preview
Benzinga Insights
Thursday, April 27, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, April 25, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
